106 related articles for article (PubMed ID: 15686929)
1. Five-member thio-heterocyclic fused naphthalimides with aminoalkyl side chains: intercalation and photocleavage to DNA.
Xu Y; Qu B; Qian X; Li Y
Bioorg Med Chem Lett; 2005 Feb; 15(4):1139-42. PubMed ID: 15686929
[TBL] [Abstract][Full Text] [Related]
2. Highly-efficient DNA photocleavers with long wavelength absorptions: thio-heterocyclic fused naphthalimides containing aminoalkyl side chains.
Qian X; Li Y; Xu Y; Liu Y; Qu B
Bioorg Med Chem Lett; 2004 May; 14(10):2665-8. PubMed ID: 15109674
[TBL] [Abstract][Full Text] [Related]
3. Novel 2-aminothiazonaphthalimides as visible light activatable photonucleases: effects of intercalation, heterocyclic-fused area and side chains.
Li Z; Yang Q; Qian X
Bioorg Med Chem Lett; 2005 Apr; 15(7):1769-72. PubMed ID: 15780603
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, antitumor evaluation and DNA photocleaving activity of novel methylthiazonaphthalimides with aminoalkyl side chains.
Li Z; Yang Q; Qian X
Bioorg Med Chem Lett; 2005 Jun; 15(12):3143-6. PubMed ID: 15876532
[TBL] [Abstract][Full Text] [Related]
5. Novel thiazonaphthalimides as efficient antitumor and DNA photocleaving agents: effects of intercalation, side chains, and substituent groups.
Li Z; Yang Q; Qian X
Bioorg Med Chem; 2005 Aug; 13(16):4864-70. PubMed ID: 15925513
[TBL] [Abstract][Full Text] [Related]
6. Bis-naphthalimides: a new class of antitumor agents.
Braña MF; Castellano JM; Morán M; Pérez de Vega MJ; Romerdahl CR; Qian XD; Bousquet P; Emling F; Schlick E; Keilhauer G
Anticancer Drug Des; 1993 Aug; 8(4):257-68. PubMed ID: 8240655
[TBL] [Abstract][Full Text] [Related]
7. Novel heterocyclic family of phenyl naphthothiazole carboxamides derived from naphthalimides: synthesis, antitumor evaluation, and DNA photocleavage.
Li Z; Yang Q; Qian X
Bioorg Med Chem; 2005 May; 13(9):3149-55. PubMed ID: 15809150
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antitumor activity, molecular modeling, and DNA binding properties of a new series of imidazonaphthalimides.
Braña MF; Cacho M; García MA; de Pascual-Teresa B; Ramos A; Acero N; Llinares F; Muñoz-Mingarro D; Abradelo C; Rey-Stolle MF; Yuste M
J Med Chem; 2002 Dec; 45(26):5813-6. PubMed ID: 12477366
[TBL] [Abstract][Full Text] [Related]
9. N-aroyloxylthioxo-naphthalimides as DNA photocleavers of aroyloxyl oxygen radicals: synthesis, evaluation, and substituents' effect.
Xu Y; Huang X; Qian X; Yao W
Bioorg Med Chem; 2004 May; 12(9):2335-41. PubMed ID: 15080930
[TBL] [Abstract][Full Text] [Related]
10. Novel naphthalimide hydroperoxide photonucleases: the role of thiocyclic-fused area and the difference in spectra, photochemistry and photobiological activity.
Xu Y; Qian X; Yao W; Mao P; Cui J
Bioorg Med Chem; 2003 Dec; 11(24):5427-33. PubMed ID: 14642587
[TBL] [Abstract][Full Text] [Related]
11. 2,6-Di(omega-aminoalkyl)-2,5,6,7-tetrahydropyrazolo[3,4,5-mn]pyrimido[5,6,1-de]acridine-5,7-diones: novel, potent, cytotoxic, and DNA-binding agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2002 Jan; 45(3):696-702. PubMed ID: 11806721
[TBL] [Abstract][Full Text] [Related]
12. Naphthalimide intercalators with chiral amino side chains: effects of chirality on DNA binding, photodamage and antitumor cytotoxicity.
Yang Q; Yang P; Qian X; Tong L
Bioorg Med Chem Lett; 2008 Dec; 18(23):6210-3. PubMed ID: 18930399
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and characterization of polyintercalating ligands.
Guelev VM; Cubberley MS; Murr MM; Lokey RS; Iverson BL
Methods Enzymol; 2001; 340():556-70. PubMed ID: 11494870
[No Abstract] [Full Text] [Related]
14. New analogues of amonafide and elinafide, containing aromatic heterocycles: synthesis, antitumor activity, molecular modeling, and DNA binding properties.
Braña MF; Cacho M; García MA; de Pascual-Teresa B; Ramos A; Domínguez MT; Pozuelo JM; Abradelo C; Rey-Stolle MF; Yuste M; Báñez-Coronel M; Lacal JC
J Med Chem; 2004 Mar; 47(6):1391-9. PubMed ID: 14998328
[TBL] [Abstract][Full Text] [Related]
15. A substituent constant analysis of the interaction of substituted naphthalene monoimides with DNA.
Stevenson KA; Yen SF; Yang NC; Boykin DW; Wilson WD
J Med Chem; 1984 Dec; 27(12):1677-82. PubMed ID: 6502597
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and DNA binding properties of novel mono and bisnaphthalimides.
Braña MF; Cacho M; Ramos A; Domínguez MT; Pozuelo JM; Abradelo C; Rey-Stolle MF; Yuste M; Carrasco C; Bailly C
Org Biomol Chem; 2003 Feb; 1(4):648-54. PubMed ID: 12929451
[TBL] [Abstract][Full Text] [Related]
17. The novel anti-tumor agents of 4-triazol-1,8-naphthalimides: synthesis, cytotoxicity, DNA intercalation and photocleavage.
Li X; Lin Y; Wang Q; Yuan Y; Zhang H; Qian X
Eur J Med Chem; 2011 Apr; 46(4):1274-9. PubMed ID: 21345546
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activities of 6-amino amonafide derivatives.
Norton JT; Witschi MA; Luong L; Kawamura A; Ghosh S; Stack MS; Sim E; Avram MJ; Appella DH; Huang S
Anticancer Drugs; 2008 Jan; 19(1):23-36. PubMed ID: 18043127
[TBL] [Abstract][Full Text] [Related]
19. New furan side tetracyclic allopsoralen derivatives: synthesis and photobiological evaluation.
Dalla Via L; Mammi S; Uriarte E; Santana L; Lampronti I; Gambari R; Gia O
J Med Chem; 2006 Jul; 49(14):4317-26. PubMed ID: 16821791
[TBL] [Abstract][Full Text] [Related]
20. Novel fluorescent markers for hypoxic cells of naphthalimides with two heterocyclic side chains for bioreductive binding.
Liu Y; Xu Y; Qian X; Liu J; Shen L; Li J; Zhang Y
Bioorg Med Chem; 2006 May; 14(9):2935-41. PubMed ID: 16403640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
